Cardiac Imaging In The VALOR-HCM Trial Cardiac Consult: A Cleveland Clinic Podcast For Healthcare Professionals podcast

Kandungan disediakan oleh Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals »
Cardiac Imaging in the VALOR-HCM Trial

4d ago 31:28

Kongsi

MP3•Laman utama episod

Mavacamten is the first and only FDA-approved cardiac myosin inhibitor to treat obstructive hypertrophic cardiomyopathy (HCM). An important factor to the success of the VALOR HCM trial was the participation of specialized cardiac sonographers and imagers.
Milind Desai, MD, MBA speaks with Jeanne Drinko, Amy Kanta and Anne Campbell about the importance of cardiac imaging.
Learn more about C5 Research at Cleveland Clinic.
https://my.clevelandclinic.org/research/c5research
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ext. 49162

298 episod

#Fitness #Cardiac Consult: For Healthcare Professionals #Cleveland Clinic #Vascular Institute #Cleveland Clinic Heart #Health Industry #Health and Well-Being #Health Care